OMX Nordic 40
2.523,26
PKT
-13,16
PKT
-0,52
%
Werbung
Analysen zu OMX Nordic 40-Werten
Datum | Rating | Analyst | |
---|---|---|---|
28.11.18 | AstraZeneca Reduce | HSBC | |
26.11.18 | Novo Nordisk Reduce | HSBC | |
26.11.18 | Novo Nordisk buy | UBS AG | |
23.11.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
23.11.18 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
23.11.18 | ABB (Asea Brown Boveri) buy | Deutsche Bank AG | |
19.11.18 | AstraZeneca Neutral | UBS AG | |
19.11.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
19.11.18 | ABB (Asea Brown Boveri) Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
19.11.18 | Nokia Outperform | Credit Suisse Group | |
19.11.18 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
16.11.18 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
16.11.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
16.11.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
14.11.18 | Nokia Outperform | Credit Suisse Group | |
13.11.18 | Fortum Sell | Goldman Sachs Group Inc. | |
13.11.18 | AstraZeneca buy | Deutsche Bank AG | |
12.11.18 | AstraZeneca Reduce | HSBC | |
12.11.18 | AstraZeneca buy | Deutsche Bank AG | |
09.11.18 | AstraZeneca Outperform | Credit Suisse Group | |
09.11.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
09.11.18 | AstraZeneca Hold | CFRA | |
09.11.18 | AstraZeneca overweight | Barclays Capital | |
08.11.18 | AstraZeneca Neutral | UBS AG | |
08.11.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
07.11.18 | ABB (Asea Brown Boveri) Hold | Baader Bank | |
06.11.18 | Fortum buy | Société Générale Group S.A. (SG) | |
06.11.18 | Novo Nordisk Reduce | HSBC | |
05.11.18 | Novo Nordisk buy | UBS AG | |
02.11.18 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
02.11.18 | Novo Nordisk buy | Deutsche Bank AG | |
02.11.18 | Novo Nordisk Hold | CFRA | |
02.11.18 | Novo Nordisk Conviction Buy | Goldman Sachs Group Inc. | |
02.11.18 | Novo Nordisk Neutral | Credit Suisse Group | |
01.11.18 | Novo Nordisk buy | UBS AG | |
01.11.18 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
31.10.18 | Nokia buy | Deutsche Bank AG | |
30.10.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
30.10.18 | ABB (Asea Brown Boveri) buy | Citigroup Corp. | |
30.10.18 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. |